Related references
Note: Only part of the references are listed.Functional G-protein-coupled receptor 35 is expressed by neurons in the CA1 field of the hippocampus
Manickavasagom Alkondon et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Targeting key dioxygenases in tryptophan-kynurenine metabolism for immunomodulation and cancer chemotherapy
Christopher J. D. Austin et al.
DRUG DISCOVERY TODAY (2015)
Cross-talk between Aryl Hydrocarbon Receptor and the Inflammatory Response A ROLE FOR NUCLEAR FACTOR-κB
Christoph F. A. Vogel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cellular mechanisms and physiological consequences of redox-dependent signalling
Kira M. Holmstroem et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases
Jazmin Reyes Ocampo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Identification of Cinnabarinic Acid as a Novel Endogenous Aryl Hydrocarbon Receptor Ligand That Drives IL-22 Production
Margaret M. Lowe et al.
PLOS ONE (2014)
The aryl hydrocarbon receptor meets immunology: friend or foe? A little of both
Walker Julliard et al.
FRONTIERS IN IMMUNOLOGY (2014)
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Iain A. Murray et al.
NATURE REVIEWS CANCER (2014)
The Role of the Immune System in Huntington's Disease
Gisa Ellrichmann et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls
Markus J. Schwarz et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease
Denes Zadori et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
3-Hydroxykynurenine and Other Parkinson's Disease Biomarkers Discovered by Metabolomic Analysis
Peter A. LeWitt et al.
MOVEMENT DISORDERS (2013)
Kynurenines in the CNS: recent advances and new questions
Laszlo Vecsei et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
3-Hydroxykynurenine: An intriguing molecule exerting dual actions in the Central Nervous System
Ana Laura Colin-Gonzalez et al.
NEUROTOXICOLOGY (2013)
Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat
Virginie Chauvel et al.
EXPERIMENTAL NEUROLOGY (2012)
Modifications on the carboxylic function of kynurenic acid
Ferenc Fueloep et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Behavioural studies with a newly developed neuroprotective KYNA-amide
Levente Gellert et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
The kynurenine system and immunoregulation
Yvette Mandi et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Mechanism of Oxidative Stress in Neurodegeneration
Sonia Gandhi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Metabolism and Pharmacokinetics of JM6 in Mice: JM6 Is Not a Prodrug for Ro-61-8048
Maria G. Beconi et al.
DRUG METABOLISM AND DISPOSITION (2012)
Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
F. Fazio et al.
MOLECULAR PHARMACOLOGY (2012)
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Daniel Zwilling et al.
CELL (2011)
Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia
Levente Gellert et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease
Denes Zadori et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis
Yiquan Chen et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients
Valentina Durastanti et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-α (TNF-α) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils
Zoltan Tiszlavicz et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: Implications of modulating kynurenate as a protective strategy
Daniela Silva-Adaya et al.
NEUROTOXICOLOGY AND TERATOLOGY (2011)
On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
R. Lugo-Huitron et al.
NEUROTOXICOLOGY AND TERATOLOGY (2011)
Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus
Paul Carrillo-Mora et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study
Mate Marosi et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis
Yiquan Chen et al.
NEUROTOXICITY RESEARCH (2010)
Glutamate receptors, neurotoxicity and neurodegeneration
Anthony Lau et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling
Brett C. DiNatale et al.
TOXICOLOGICAL SCIENCES (2010)
Syntheses, Transformations and Pharmaceutical Applications of Kynurenic Acid Derivatives
F. Fueloep et al.
CURRENT MEDICINAL CHEMISTRY (2009)
On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo
Laura Amori et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Mechanism for Quinolinic Acid Cytotoxicity in Human Astrocytes and Neurons
Nady Braidy et al.
NEUROTOXICITY RESEARCH (2009)
The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons
Abdur Rahman et al.
PLOS ONE (2009)
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys
Laurent Gregoire et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
GPR35 is a functional receptor in rat dorsal root ganglion neurons
Hiroyuki Ohshiro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Tryptophan-derived ultraviolet filter compounds covalently bound to lens proteins are photo sensitizers of oxidative damage
Jasminka Mizdrak et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
The Janus-face kynurenic acid
Eva Rozsa et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate
Hermina Robotka et al.
LIFE SCIENCES (2008)
Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus
Katalin Sas et al.
NEUROBIOLOGY OF DISEASE (2008)
Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge:: A role for IFN-γ?
Thomas J. Connor et al.
NEUROSCIENCE LETTERS (2008)
Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor
Maureen K. Bunger et al.
TOXICOLOGICAL SCIENCES (2008)
Characterization of the kynurenine pathway in human neurons
Gilles J. Guillemin et al.
JOURNAL OF NEUROSCIENCE (2007)
Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis
K. Rejdak et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway
Masanori Kitamura et al.
CANCER LETTERS (2007)
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
Katalin Sas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Prooxidant action of rosmarinic acid: Transition metal-dependent generation of reactive oxygen species
Keiko Murakami et al.
TOXICOLOGY IN VITRO (2007)
Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine
Fernanda G. De Felice et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Indoleamine 2,3-dioxygenase in materno-fetal interaction
Peter Sedlmayr
CURRENT DRUG METABOLISM (2007)
Kynurenines impair energy metabolism in rat cerebral cortex
Patricia Fernanda Schuck et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2007)
In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain
Guilhian Leipnitz et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
Michael T. Lin et al.
NATURE (2006)
Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35
Jinghong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Kynurenic acid has a dual action on AMPA receptor responses
Christina Prescott et al.
NEUROSCIENCE LETTERS (2006)
Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine
Gary L. Wenk et al.
BEHAVIOURAL PHARMACOLOGY (2006)
Kynurenine metabolism in multiple sclerosis
Z Hartai et al.
ACTA NEUROLOGICA SCANDINAVICA (2005)
Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus
GJ Guillemin et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
Interferon-β affects the tryptophan metabolism in multiple sclerosis patients
A Amirkhani et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys
P Samadi et al.
MOVEMENT DISORDERS (2005)
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
ML Block et al.
PROGRESS IN NEUROBIOLOGY (2005)
Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons
W Rzeski et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
The mechanism of inactivation of 3-hydroxyanthranilate-3,4-dioxygenase by 4-chloro-3-hydroxyanthranilate
KL Colabroy et al.
BIOCHEMISTRY (2005)
Involvement of quinolinic acid in AIDS dementia complex
GJ Guillemin et al.
NEUROTOXICITY RESEARCH (2005)
Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease
P Guidetti et al.
NEUROBIOLOGY OF DISEASE (2004)
Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis
J Ilzecka et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients
K Rejdak et al.
NEUROSCIENCE LETTERS (2002)
T cell apoptosis by tryptophan catabolism
I Fallarino et al.
CELL DEATH AND DIFFERENTIATION (2002)
Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes
RG Tavares et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Increased neopterin production and tryptophan degradation in advanced Parkinson's disease
B Widner et al.
JOURNAL OF NEURAL TRANSMISSION (2002)
IFN-β1b induces kynurenine pathway metabolism in human macrophages:: Potential implications for multiple sclerosis treatment
GJ Guillemin et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
GJ Guillemin et al.
JOURNAL OF NEUROCHEMISTRY (2001)
3-Hydroxyanthranilic acid, an L-tryptopban metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon-γ
T Morita et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2001)
Early and progressive accumulation of reactive microglia in the Huntington disease brain
E Sapp et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1α and-1β in macrophages
MC Bosco et al.
JOURNAL OF IMMUNOLOGY (2000)
Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus
HQ Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Tryptophan degradation and immune activation in Alzheimer's disease
B Widner et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions
S Vazquez et al.
FREE RADICAL RESEARCH (2000)
Copper-ligand interactions and physiological free radical processes. Part 3. Influence of histidine, salicylic acid and anthranilic acid on copper-driven fenton chemistry in vitro
S Gaubert et al.
FREE RADICAL RESEARCH (2000)
Share Paper
